In a randomized controlled trial called the “Evaluate the Clinical use of vitamin K Supplementation in Postmenopausal Women with Osteopenia” trial, Angela Cheung and colleagues at the University of Toronto found that a high dose daily vitamin K1 supplement did not protect against age-related bone mineral density decline.